Search
Main Menu
Main Content
Fermer
Choose language
FR
EN
Accessibility
Change contrast :
Standards
Reinforced
icone
HAS profile
Mission
Organisational Structure
Ethics, transparency and management of conflicts of interest
International relations and projects
Publications
English content
Medicines
Opinions on medical devices
INAHTA briefs
French website
Chercher
Recherche
icone plus
English content
Les recommandations et guides
Les médicaments
Les actes professionnels
Les dispositifs médicaux
Les médecins accrédités
Les articles d'information
Les établissements de santé
Chercher
My account
My account
Email alert Subscription
Newsletter Subscription
My search
Refresh
Please fill in your email address to retrieve your email alerts subscriptions.
New subscription
Please fill in your email address to retrieve your newsletter subscriptions.
You do not have a saved search
Mon Compte
Sélection
No element in selection
Favoris
Sélection
Établissements de santé
Contact
Abonnez-vous aux actualités
7 results
Active substance : rifampicine
Topics : Diseases and conditions
OK
Chercher
Filter
Topic
Diseases and conditions
(7)
Plus ...
Respiratory tract diseases
(4)
Plus ...
Pulmonary and pleural diseases
(4)
Bronchial diseases
(1)
Infectious diseases
(4)
Plus ...
Bacterial infections
(4)
Congenital, genetic and rare diseases
(2)
Nervous system diseases
(1)
Plus ...
Central nervous system diseases
(1)
Blood and lymphatic diseases
(1)
Plus ...
Bone marrow diseases
(1)
Anemia and hemoglobinopathies
(1)
Digestive system diseases
(1)
Plus ...
Pancreatic and biliary tract diseases
(1)
Population groups
(3)
Plus ...
Paediatrics
(3)
Diagnostic and therapeutic techniques
(2)
Plus ...
Diagnostic techniques and procedures
(2)
Plus ...
Biology (laboratory tests)
(2)
Economics and public health
(1)
Plus ...
Organisation of care
(1)
Content type
Practice Guidelines and Other Guides
(5)
Plus ...
Practice guidelines
(3)
Chronic disease guide
(2)
Drugs, devices and medical acts
(2)
Plus ...
Health technology assessment
(2)
Date
Last five years
(1)
Manufacturer
alter
(1)
industriels
(1)
Language
Français
(7)
Active substance
aciclovir
(1)
acide clavulanique
(2)
acide fusidique
(2)
acide nalidixique
(1)
alcool
(2)
alemtuzumab
(1)
allopurinol
(2)
amikacine
(1)
aminophylline
(1)
amoxicilline
(3)
aspirine
(1)
atovaquone
(1)
azathioprine
(1)
busulfan
(1)
carbachol
(1)
carbimazole
(1)
ceftazidime
(2)
ceftriaxone
(2)
chloroquine
(1)
chlorpropamide
(1)
ciclosporine
(1)
ciprofloxacine
(5)
clarithromycine
(1)
clindamycine
(1)
cloxacilline
(1)
cyclophosphamide
(1)
danazol
(1)
eltrombopag
(1)
fer
(1)
fluconazole
(1)
flunisolide
(1)
gentamicine
(1)
halothane
(1)
iode
(1)
isoniazide
(2)
itraconazole
(2)
josamycine
(1)
leucine
(1)
lopinavir
(1)
mannitol
(1)
mezlocilline
(1)
norfloxacine
(1)
pentoxifylline
(1)
piroxicam
(1)
posaconazole
(1)
prednisolone
(2)
prednisone
(1)
primidone
(1)
pristinamycine
(1)
propionate de fluticasone
(1)
pyrazinamide
(2)
rifabutine
(1)
rifampicine
(7)
ritonavir
(1)
rituximab
(1)
romiplostim
(1)
roxithromycine
(1)
salbutamol
(1)
sirolimus
(1)
sodium
(1)
stiripentol
(1)
sulfasalazine
(1)
tacrolimus
(1)
tazobactam
(2)
tobramycine
(2)
valaciclovir
(1)
vancomycine
(2)
voriconazole
(1)
More filter
Save your search
Search Export
Practice guidelines and other guides
- 5 results
Acquired and inherited aplastic anemia
Chronic disease guide
- Posted on 4/5/2024
Download
guide
Add to
my selection
Active tuberculosis
Chronic disease guide
- Posted on 19/6/2017
Add to
my selection
Antibiotic therapy and prevention of bacterial resistance in healthcare organisations
Practice guidelines
- Posted on 29/5/2008
Download
abstract
Add to
my selection
See 5 result in Practice Guidelines and Other Guides
Drugs, devices and medical acts
- 2 results
Assessment of tests for meningococci (Neisseria meningitidis) and pneumococci (Streptococcus pneumoniae) using gene amplification in the diagnosis of meningitis - INAHTA Brief
Health technology assessment
- Posted on 25/5/2016
Download
document
Add to
my selection
Interferon-gamma release assays as in vitro screening tests for latent tuberculosis infection
Health technology assessment
- Posted on 29/6/2015
Download
document
Add to
my selection
Français
English
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
1RLt2hBD39xLbYNw